Evaluating the treatment of metastatic colorectal cancer with monoclonal antibodies.

Journal of medicine and life

Volumn 5, Issue 2, 2012, Pages 168-172

  Popa, C ^a   Ionescu, S ^b   Mihaila D ^b   Gal, I ^b   Poteca T ^b   Simion, S ^b  

^a Carol Davila School of Medicine   (Romania)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BIOLOGICAL FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; KRAS PROTEIN, HUMAN; MONOCLONAL ANTIBODY; ONCOPROTEIN; RAS PROTEIN;

ARTICLE; BIOLOGICAL THERAPY; COLORECTAL TUMOR; DISEASE COURSE; DRUG EFFECT; GENETICS; HUMAN; K-RAS MUTATIONS; METABOLISM; METASTASIS; METASTATIC COLORECTAL CANCER; MONOCLONAL ANTIBODIES; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR BIOMARKERS;

BIOLOGIC THERAPY; K-RAS MUTATIONS; METASTATIC COLORECTAL CANCER; MONOCLONAL ANTIBODIES; TUMOR BIOMARKERS;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; BIOLOGICAL FACTORS; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; HUMANS; NEOPLASM METASTASIS; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION;

EID: 84884562946     PISSN: None     EISSN: 18443117     Source Type: Journal    
DOI: None     Document Type: Article

References (0)